Scleroderma Clinical Trials in Durham, North Carolina
3 recruitingDurham, North Carolina
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
SclerodermaSystemic Sclerosis
Cabaletta Bio12 enrolled10 locationsNCT06328777
Recruiting
Phase 2
Platform Clinical Study for Conquering Scleroderma
SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072
Recruiting
Maternal Autoimmune Disease Research Alliance (MADRA) Registry
Rheumatoid ArthritisSclerodermaSystemic Lupus Erythematosus+4 more
Duke University1,000 enrolled1 locationNCT03276923